GB843073A - 2-methyl-3-orthotolyl-4-quinazolone and acid addition salts thereof - Google Patents

2-methyl-3-orthotolyl-4-quinazolone and acid addition salts thereof

Info

Publication number
GB843073A
GB843073A GB27082/58A GB2708258A GB843073A GB 843073 A GB843073 A GB 843073A GB 27082/58 A GB27082/58 A GB 27082/58A GB 2708258 A GB2708258 A GB 2708258A GB 843073 A GB843073 A GB 843073A
Authority
GB
United Kingdom
Prior art keywords
methyl
addition salts
quinazolone
acid addition
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB27082/58A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TORAUDE LAB
Original Assignee
TORAUDE LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TORAUDE LAB filed Critical TORAUDE LAB
Publication of GB843073A publication Critical patent/GB843073A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention comprises 2-methyl-3-o-tolyl-4-quinazolone and acid addition salts thereof, the preparation thereof by condensing N-acetyl anthranilic acid with ortho-toluidine and, if desired, converting the product into its acid addition salts, and also pharmaceutical compositions containing the products (see Group VI). The products have hypnotic properties.ALSO:Pharmaceutical hypnotic compositions comprise 2-methyl-3-O-tolyl-4-quinazolone and acid-addition salts thereof, singly or together with mebubarbital, methyl pentynol reserpine or chlorpromazine, with pharmaceutical carriers. Preparations may be in the form of tablets, capsules and suppositories in which the active materials are mixed with cocoa butter or a polyethylene glycol polymer.
GB27082/58A 1958-05-09 1958-08-22 2-methyl-3-orthotolyl-4-quinazolone and acid addition salts thereof Expired GB843073A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US843073XA 1958-05-09 1958-05-09

Publications (1)

Publication Number Publication Date
GB843073A true GB843073A (en) 1960-08-04

Family

ID=22184119

Family Applications (1)

Application Number Title Priority Date Filing Date
GB27082/58A Expired GB843073A (en) 1958-05-09 1958-08-22 2-methyl-3-orthotolyl-4-quinazolone and acid addition salts thereof

Country Status (1)

Country Link
GB (1) GB843073A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081231A (en) * 1960-10-27 1963-03-12 Wallace & Tiernan Inc Appetite suppressant mixture having decreased side effects
US3092631A (en) * 1963-06-04 Y-chloro-z-lower alkyl-i
DE1224316B (en) * 1961-03-18 1966-09-08 Beiersdorf & Co Ag P Process for the preparation of 2-methyl-3- (o-aethylphenyl) -4-oxo-3, 4-dihydroquinazoline and its salts
EP0316668A2 (en) * 1987-11-16 1989-05-24 MERCK PATENT GmbH Use of a tetrahydro-pyrido(2,3-d)pyrimidine for obtaining an analgetic agent

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092631A (en) * 1963-06-04 Y-chloro-z-lower alkyl-i
US3081231A (en) * 1960-10-27 1963-03-12 Wallace & Tiernan Inc Appetite suppressant mixture having decreased side effects
DE1224316B (en) * 1961-03-18 1966-09-08 Beiersdorf & Co Ag P Process for the preparation of 2-methyl-3- (o-aethylphenyl) -4-oxo-3, 4-dihydroquinazoline and its salts
EP0316668A2 (en) * 1987-11-16 1989-05-24 MERCK PATENT GmbH Use of a tetrahydro-pyrido(2,3-d)pyrimidine for obtaining an analgetic agent
EP0316668A3 (en) * 1987-11-16 1990-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Analgesic

Similar Documents

Publication Publication Date Title
IE40025B1 (en) Hexahydro-dibenzo (b,d) pyran-9-ones as psychotropic or sedative drugs
IT1143959B (en) PERFECTION IN THE TABLETS, IN PARTICULAR OF PHARMACEUTICAL PRODUCTS WITH THE POSSIBILITY OF MULTIPLE FRACTION FOR THE DIVISION IN UNIT DOSES AND SUB-DOSE
GB843073A (en) 2-methyl-3-orthotolyl-4-quinazolone and acid addition salts thereof
DE3272602D1 (en) Solid galenic form for oral administration and process for its preparation
IL61207A0 (en) Cytostatically active pharmaceutical compositions comprising isocyanuric acid derivatives, certain such novel derivatives and their preparation
IL27013A (en) Homologs of n,n'-bis(benzoyloxyalkyl)-piperazine,their preparation and pharmaceutical compositions containing them
GB1202148A (en) Pharmaceutical compositions
IL61406A0 (en) Pharmaceutical compositions for injection comprising a penicillin or salt thereof
IL30231A0 (en) N-disubstituted 3-amino-1,2-benzisothiazoles,their preparation and pharmaceutical compositions containing them
GB1346405A (en) Pharmaceutical composition useful as an anti-depressant agent and an anti-parkinsonism agent
IL45865A0 (en) 4-oxo-2-imidazolidinylidene ureas,their preparation and pharmaceutical compositions containing them
GB1174362A (en) Oral Medicants for Haemorrhoids.
GB1454872A (en) Anticonvulsant
ES250851A1 (en) N,n-dimethyl-2-phenyl-2-benzoyloxymethylbutylamine
GB1279686A (en) Pharmaceutical composition and mental illness treatment pack
DE2861571D1 (en) Amidines, their preparation and pharmaceutical compositions containing them.
GB874520A (en) Amphetamine barbiturates and compositions thereof
IL26620A (en) 1,2-dihydroquinoline-n-carboxylic and thionocarboxylic acid esters,their preparation and pharmaceutical compositions containing them
IT8050159A0 (en) CHINAZOLINONE DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THIS PRODUCT
GB783845A (en) Pharmaceutical composition and preparation thereof
GB878284A (en) 1-o-tolyloxyethyl-4-phenyl-piperidine
OA01156A (en) A process for manufacturing products based on fruits, seeds, plants and other plants in solid, powder or liquid form intended for the preparation of hot or cold drinks.
AU258419B2 (en) Substituted alkylene diamines process for their preparation and pharmaceutical compositions containing same
AU433912B2 (en) Aminohalogeno-phenyl ethanolamines, their preparation and pharmaceutical compositions containing them
GB884576A (en) Pharmaceutical compositions comprising an alkylamino substituted barbituric acid and salts thereof